Dermatol. praxi. 2016;10(2):84-87 | DOI: 10.36290/der.2016.020

New possibilities extemporaneous preparation in dermatology - innovative foam base Espumil

PharmDr. Sylva Klovrzová1,2, Mgr. Soňa Brtnová1, MUDr. Lada Novotná3
1 Lékárna Galenika, Praha 6
2 Farmaceutická fakulta UK, Katedra Farmaceutické technologie, Hradec Králové
3 Oblastní nemocnice Mladá Boleslav

The foam base Espumil extends the possibilities of extemporaneous preparation in the pharmacies. The article presents the utilisation of Espumil as a base for drugs commonly used in dermatology, such as dexamethasone, ichthyol, miconazole, chlorhexidine and minoxidil. These foam products are suitable for the administration onto the hair and hairy skin.

Keywords: dermatology, extemporaneuous preparation, foam base, EspumilTM

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klovrzová S, Brtnová S, Novotná L. New possibilities extemporaneous preparation in dermatology - innovative foam base Espumil. Dermatol. praxi. 2016;10(2):84-87. doi: 10.36290/der.2016.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Geiger CM, Sorenson B, Whaley PA. Stability of Minoxidil in Espumil Foam Base. Int J Pharm Compd. 2013; 17(2): 165-167.
    2. ČR, MINISTERSTVO ZDRAVOTNICTVÍ. Český lékopis 2009. Doplněk 2015. [CD-ROM] Praha: Grada Publ.
    3. Michalíková H. Léčba alopecie. Klin Farmakol Farm. 2006; 20: 211-214.
    4. Bansal M, Manchanda K, Sunder Pandey S. Role of Caffeine in the Management of Androgenetic Alopecia. Int J Trichology. 2012; 4(3): 185-186. Go to original source... Go to PubMed...
    5. Blume-Peytavi U, Lönnfors S, a kol. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. Journal of the American Academy of Dermatology. 2012; 66(5): 794-800. Go to original source... Go to PubMed...
    6. Ditrichová D. Ichtamol a dehty v současné dermatologické terapii. Klin Farmakol Farm. 2005; 19: 47-48.
    7. DEUTSCHER ARZNEIMITTEL-CODEX (DAC)/ NEUES REZEPTUR-FORMULARIUM (NRF) 2015, Govi-Verlag Eschborn, Deutscher Apotheker-Verlag, Stuttgart, 2015; ISBN 978-3-7741-0044-2.
    8. Hašek J. Nové léčivé látky v magistraliter receptuře XIV - mikonazol a mikonazol-nitrát. Prakt. lékáren. 2013; 9(4-5): 192-195.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.